Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Eur J Drug Metab Pharmacokinet. 2018 Oct;43(5):543–554. doi: 10.1007/s13318-018-0464-z

Figure 4.

Figure 4

Tissue distribution of 14C-C3. Following single-dose i.p. (a), or chronic 7-day i.p. pump administration (b) of radiolabeled C3, tissues were collected, homogenized and analyzed for radioactivity. Data were transformed to μg 14C-C3 per gm tissue and normalized to dose for comparison.